SLC2A1 and cystic fibrosis: The mTOR pathway is activated in CF airway neutrophils (85), and glucose transporter 1 (Glut1) and inorganic phosphate transporter 1 (PiT1) expression both increase (86), all of which promotes glucose utilization in the airways (87).